We're excited to share the Isolator® Synergy™ EnCompass® Clamp has received regulatory approval in CE-marked countries in Europe!

AtriCure’s portfolio of bipolar radiofrequency (RF) ablation devices have been used in over 575,000 cases, backed by continuous innovation, clinical science, and education. The EnCompass clamp is our latest RF device providing a simpler and faster approach to ablating the heart in open-chest procedure.

Read the full release to learn more: <a href="https://okt.to/Qntpc3&quot; target="_blank">https://okt.to/Qntpc3</a&gt;